Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Multiple malaria infections may worsen disease
Blood cells
The body’s response to the first infection produces more of the type of red blood cell that the second parasite requires.

One type of parasite helps the other to survive

Scientists at the University of Edinburgh have discovered why infections with two types of malaria parasite lead to greater health risks.

A study, published in the journal Ecology Letters, describes how researchers found that one type of parasite helps the other to survive.

In humans, a parasite known as P.falciparum infects red blood cells of all ages, while another - P.vivax - only attacks young red blood cells.

But a new study in mice with equivalent malaria parasites shows that the body’s response to the first infection produces more of the type of red blood cell that the second parasite requires.

Millions of red blood cells are destroyed in response to the first reaction, and the body responds by replenishing these cells, the scientists explain. These fresh cells quickly become infected by the second type of parasite, making the infection worse.

Researchers say the finding could explain why infections from both P.falciparum and P.vivax in humans have worse outcomes for patients than single infections.

"Immune responses are assumed to determine the outcome of interactions between parasite species but our study clearly shows that resources can be more important,” said Professor Sarah Reece of the University of Edinburgh’s School of Biological Sciences.

“Our findings also challenge ideas that one species will outcompete the other, which explains why infections involving two parasite species can pose a greater health risk to patients,” she adds. 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'